Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Immunol. 2016 Dec 3;185:3–9. doi: 10.1016/j.clim.2016.11.019

Table 2. Histopathologic Worsening Multivariate Cox Proportional Hazard Ratio Analysis.

Upper section evaluates time to ESRD, adjusting for multiple factors and lower evaluates time to death.

ESRD
Parameter Description Regression Coefficient p-Value Hazard Ratio
Age at First Renal Biopsy
 Age 18–50 ref. ref.
 Age<18 & Age>50 at First Renal Biopsy −1.036 0.037 0.355
Gender
 Female ref. ref.
 Male 0.091 0.830 1.095
Race/Ethnicity
 White ref. ref.
 Hispanic Ethnicity 0.620 0.325 1.859
 Black Race 0.458 0.459 1.580
First Biopsy Histopathologic Classification
 Mesangial (II) ref. ref.
 Membranous (V) 0.873 0.291 2.395
 Proliferative (III, IV, III+V, IV+V) 1.484 0.048 4.411
Induction Therapy
 Other (AZA, CYA) ref. ref.
 CYC 0.208 0.845 1.231
 MMF 0.438 0.681 1.549
 None or Unknown Induction Therapy −0.464 0.689 0.629
Second Biopsy Compared to First
 Same or Improved ref. ref.
 Worse 1.426 0.0001 4.160
DEATH
Parameter Description Regression Coefficient p-Value Hazard Ratio
Age at First Renal Biopsy
 Age 18–50 ref. ref.
 Age<18 & Age>50 at First Renal Biopsy −0.562 0.281 1.754
Gender
 Female ref. ref.
 Male 0.495 0.397 1.641
Race/Ethnicity
 White ref. ref.
 Hispanic Ethnicity 0.049 0.954 1.050
 Black Race 0.206 0.796 1.229
First Biopsy Histopathologic Classification
 Mesangial (II) ref. ref.
 Membranous (V) 0.185 0.835 1.203
 Proliferative (III, IV, III+V, IV+V) 0.108 0.895 1.114
Induction Therapy
 Other (AZA, CYA) ref. ref.
 CYC 0.377 0.746 1.457
 MMF 0.312 0.799 1.366
 None or Unknown Induction Therapy 1.165 0.344 3.206
Second Biopsy Compared to First
 Same or Improved ref. ref.
 Worse 1.458 0.022 4.297